EA202090551A1 - ENHANCING THE EFFECT FROM RELEASE OF ADENOSINTRIPHOSPHATE (ATP) - Google Patents

ENHANCING THE EFFECT FROM RELEASE OF ADENOSINTRIPHOSPHATE (ATP)

Info

Publication number
EA202090551A1
EA202090551A1 EA202090551A EA202090551A EA202090551A1 EA 202090551 A1 EA202090551 A1 EA 202090551A1 EA 202090551 A EA202090551 A EA 202090551A EA 202090551 A EA202090551 A EA 202090551A EA 202090551 A1 EA202090551 A1 EA 202090551A1
Authority
EA
Eurasian Patent Office
Prior art keywords
atp
release
adenosintriphosphate
enhancing
effect
Prior art date
Application number
EA202090551A
Other languages
Russian (ru)
Inventor
Стефани Шанто
Николя Гурден
Карин Патурель
Иван Перро
Бенжамин Росси
Original Assignee
Иннейт Фарма
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Иннейт Фарма filed Critical Иннейт Фарма
Priority claimed from PCT/EP2018/081364 external-priority patent/WO2019096900A1/en
Publication of EA202090551A1 publication Critical patent/EA202090551A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Настоящее изобретение относится к способам применения соединений, которые ингибируют ферментативную активность растворимого CD39 человека, при лечении рака для усиления активности агента или терапии, которые вызывают внеклеточное высвобождение АТФ из опухолевых клеток и/или гибель опухолевых клеток.The present invention relates to methods of using compounds that inhibit the enzymatic activity of human soluble CD39 in the treatment of cancer to enhance the activity of an agent or therapy that causes extracellular release of ATP from tumor cells and / or death of tumor cells.

EA202090551A 2018-09-19 2018-11-15 ENHANCING THE EFFECT FROM RELEASE OF ADENOSINTRIPHOSPHATE (ATP) EA202090551A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862733175P 2018-09-19 2018-09-19
PCT/EP2018/081364 WO2019096900A1 (en) 2017-11-15 2018-11-15 Potentiating the effect of atp release

Publications (1)

Publication Number Publication Date
EA202090551A1 true EA202090551A1 (en) 2021-02-01

Family

ID=74855468

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202090551A EA202090551A1 (en) 2018-09-19 2018-11-15 ENHANCING THE EFFECT FROM RELEASE OF ADENOSINTRIPHOSPHATE (ATP)

Country Status (1)

Country Link
EA (1) EA202090551A1 (en)

Similar Documents

Publication Publication Date Title
MX2021013830A (en) Ezh2 inhibitors for treating lymphoma.
EA201790195A1 (en) METHODS OF TREATING CANCER WITH THE USE OF TIGIT INHIBITORS AND ANTI-CANCER AGENTS
EA201990665A1 (en) HPK1 REGULATORS BASED ON PYRAZOLOPYRIDINE DERIVATIVES AND THEIR APPLICATION FOR TREATMENT OF CANCER
SA519401522B1 (en) Anti-LAG-3 Antibodies and Compositions
MX2019010848A (en) Compositions and methods for treating cancer.
BR112020009655A8 (en) ANTIBODY, USES OF AN ANTIBODY AND USE OF A PHARMACEUTICAL COMBINATION
MX2016007351A (en) Combination therapy for treating cancer.
MX2017013142A (en) Combination therapy for treating cancer.
MX2019010601A (en) Combination therapy for treating cancer.
EA201792191A1 (en) FGFR / PD-1 COMBINED THERAPY FOR THE TREATMENT OF MALIGNANT TUMOR
EA201692511A1 (en) COMBINED TREATMENT WITH GLUTAMINASE INHIBITORS
MX2022014277A (en) Methods for better delivery of active agents to tumors.
WO2015009726A3 (en) Medical uses of cd38 agonists
EA201792509A1 (en) CANCER TREATMENT
MX2023007212A (en) Epinephrine spray formulations.
MX2018002344A (en) Method for treating cancer.
WO2019090347A8 (en) Adenosine pathway inhibitors for cancer treatment
EA201990567A1 (en) COMBINED THERAPY WITH GLUTAMINASE INHIBITORS
MX2019013862A (en) Combination therapy.
EA202092518A1 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER
SA519410324B1 (en) Epinephrine spray formulations
MX2017013666A (en) Anti-fugetactic agent and immunotherapy agent combination therapy and compositions for the treatment of cancer.
EA202090551A1 (en) ENHANCING THE EFFECT FROM RELEASE OF ADENOSINTRIPHOSPHATE (ATP)
EA202192964A1 (en) COMBINATION THERAPY
EA202092652A1 (en) WAYS TO USE CD24 TO PREVENT AND TREAT LEUKEMIA RECURRENCE